+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Breast Biopsy Market - Global Forecast to 2030- Product Image
Breast Biopsy Market - Global Forecast to 2030- Product Image
New

Breast Biopsy Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6083426
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Breast Biopsy Market grew from USD 1.09 billion in 2024 to USD 1.20 billion in 2025. It is expected to continue growing at a CAGR of 9.31%, reaching USD 1.87 billion by 2030.

The breast biopsy landscape serves as a critical bridge between diagnostic imaging and definitive patient care decisions. As imaging modalities continue to advance, the demand for accurate, minimally invasive tissue sampling escalates. Clinicians rely on biopsy procedures not only to confirm malignancies but also to guide therapeutic strategies and monitor treatment responses. This dynamic interplay between technology innovation and clinical need underscores the importance of understanding the complex forces shaping biopsy adoption.

In recent years, improvements in imaging guidance, needle design, and robotic assistance have transformed both patient experience and diagnostic yield. These advancements occur against a backdrop of shifting reimbursement structures, regulatory changes, and evolving patient expectations for precision medicine. Consequently, stakeholders-from device manufacturers to healthcare providers-must remain attuned to emerging trends to maintain a competitive edge and optimize patient outcomes. This introduction sets the stage for an in-depth exploration of the pivotal shifts, regulatory influences, segmentation nuances, regional dynamics, and key players driving the breast biopsy market today.

Transformative Shifts in the Breast Biopsy Landscape

A new era in breast biopsy is unfolding as multidisciplinary collaboration, digital integration, and personalized medicine converge. First, the integration of artificial intelligence into imaging guidance platforms elevates lesion targeting accuracy, reducing procedure times and patient discomfort. At the same time, the rise of robotic-assisted biopsy systems enhances operator precision and consistency, particularly when sampling small or deep-seated lesions. These innovations are complemented by the growing adoption of vacuum-assisted core devices, which balance sample volume with minimally invasive technique.

Furthermore, patient-centric care models emphasize same-day diagnosis and reduced follow-up visits, prompting clinics to streamline workflows and invest in versatile systems capable of accommodating stereotactic, ultrasound, and magnetic resonance guidance. As telehealth expands, pre-procedure planning now often incorporates remote image review and virtual consultations, thereby accelerating decision-making. Altogether, these transformative shifts underscore a movement toward faster, more accurate, and less invasive biopsy pathways-reshaping expectations for both clinicians and patients alike.

Cumulative Impact of United States Tariffs 2025 on Biopsy Technologies

As of 2025, newly implemented tariffs on imported biopsy devices and imaging accessories impose additional costs throughout the supply chain. Healthcare providers are encountering higher acquisition expenses for guidance systems, biopsy guns, and vacuum-assisted needles, prompting procurement teams to renegotiate contracts or explore domestic sourcing. These increased costs cascade into operational budgets, compelling many facilities to reassess equipment upgrade timelines and maintenance strategies.

Simultaneously, manufacturers face pressure to localize production or reconfigure supply chains to mitigate tariff impacts. Several device producers have announced plans to expand regional assembly lines and seek alternative component suppliers. Although these measures require upfront investment, they aim to stabilize pricing and preserve market access. Looking ahead, the cumulative effect of these tariffs will likely accelerate consolidation among suppliers and drive innovation in cost-efficient device design. Stakeholders that proactively adapt to this new tariff environment can sustain competitive pricing while continuing to deliver high-quality biopsy solutions.

Key Segmentation Insights Across Techniques, Products, Applications, End-Users, and Technologies

When examining the landscape through the lens of biopsy technique, MRI-guided biopsy-including vacuum-assisted core biopsy-has gained traction in dense breast tissue, while open surgical biopsy subdivided into excisional and incisional approaches remains the definitive standard in complex cases, albeit with longer recovery times. Stereotactic biopsy, supported by three-dimensional mammography guidance, strikes a balance between precision and patient convenience, and ultrasound-guided methods range from core needle biopsy to fine needle aspiration, appealing to practices prioritizing real-time visualization.

From a product line perspective, biopsy guidance systems divide into stereotactic platforms and ultrasound-based units, each optimized for specific clinical scenarios. Biopsy guns present both automatic and semi-automatic variants, providing options for variable sample control. Needles further specialize into core, fine, and vacuum-assisted designs, addressing diverse tissue sampling requirements.

Application segmentation reveals that diagnostic uses, such as cancer detection and pre-cancerous lesion identification, demand high sensitivity, whereas prognostic applications-including disease progression monitoring and therapy efficacy evaluation-require consistent sample quality and repeatability. End-user analysis shows that ambulatory surgical centers, whether freestanding or hospital-affiliated, often favor streamlined, portable setups; diagnostic centers emphasize dedicated imaging suites; and hospitals invest in comprehensive systems that support complex cases and high procedure volumes.

Lastly, technology segmentation highlights non-surgical imaging options like digital mammography, MRI, and ultrasound, alongside robotic-assisted biopsy procedures featuring automated needle control systems and precision robotics. This multifaceted segmentation framework enables stakeholders to tailor strategies that align with procedural requirements, clinical objectives, and patient preferences.

Key Regional Insights: Americas, Europe, Middle East & Africa, Asia-Pacific

In the Americas, established reimbursement pathways and the presence of leading device manufacturers drive widespread adoption of advanced biopsy solutions. Providers in this region are early adopters of robotic-assisted systems and AI-augmented imaging platforms, leveraging strong research collaborations and venture capital support. In contrast, Europe, the Middle East & Africa present a diverse regulatory mosaic; Western European nations benefit from streamlined approvals and cost-sharing models, while emerging markets within EMEA manage budget constraints by prioritizing scalable ultrasound-guided and stereotactic systems. Collaborative procurement initiatives and shared training programs are increasingly common across the region.

Meanwhile, Asia-Pacific markets display considerable heterogeneity. In developed markets such as Japan and Australia, there is robust uptake of MRI-guided and robotic platforms, underpinned by high healthcare expenditure. Conversely, in fast-growing economies across Southeast Asia and South Asia, emphasis falls on cost-effective solutions-such as core needle and fine needle aspiration biopsy-often integrated within community clinics. Public-private partnerships and localized manufacturing ventures are catalyzing greater access to modern biopsy modalities, balancing affordability with diagnostic accuracy.

Key Company Insights Driving Breast Biopsy Innovation

Leading innovation in the biopsy arena stems from a diverse array of companies. Argon Medical continues to refine its needle and guidewire offerings, focusing on enhanced ergonomics. Becton, Dickinson, and Company invests heavily in integrated biopsy systems that unite guidance and sampling tools. Bio-Rad Laboratories champions advanced assay platforms that augment tissue diagnostics post-procedure. Biocept accelerates liquid biopsy integration, creating synergies between tissue and fluid sampling.

Cook Group Incorporated maintains a strong presence in minimally invasive device design, while CooperSurgical advances image-guided platforms for both percutaneous and open surgical procedures. F. Hoffmann-La Roche leverages its diagnostic portfolio to enrich pre-biopsy imaging protocols. Fluxion Biosciences refines microfluidic technologies, enhancing downstream molecular analyses. FUJIFILM Corporation integrates high-resolution imaging with biopsy guidance for seamless workflows.

GE HealthCare, Siemens Healthineers, and Thermo Fisher Scientific harness scale to deliver end-to-end solutions spanning imaging hardware to consumables. Guardant Health and Illumina pioneer genomic assays that complement tissue sampling. Halma plc, Hologic, Inc., and Johnson & Johnson Services streamline procedural safety and infection control. INRAD’s needle innovations yield improved patient comfort, while Iskus Health and TransMed7 introduce next-generation minimally invasive platforms. Leica Biosystems and Medtronic focus on pathology workflow integration, Merit Medical Systems and Sysmex enhance sample handling, and Trivitron’s regional manufacturing footprint bolsters accessibility. Collectively, these players shape a competitive ecosystem driven by cross-disciplinary collaboration and incremental device refinement.

Actionable Recommendations for Industry Leaders in Breast Biopsy Market

Industry leaders should prioritize five strategic imperatives to maintain momentum. First, diversifying the supply chain by establishing regional manufacturing hubs will mitigate tariff-related cost pressures and safeguard throughput. Second, investing in platform interoperability-linking imaging, biopsy devices, and data analytics-will create seamless workflows that enhance clinician productivity. Third, adopting modular product designs allows rapid customization for specific patient populations and procedural settings, reducing time to market. Fourth, forging partnerships with pathology providers and molecular diagnostics companies will enrich the clinical value proposition by integrating histopathology with biomarker insights. Finally, implementing robust training and support programs for end-users, including virtual reality simulations and remote mentorship, will accelerate adoption of novel technologies while ensuring procedural consistency and patient safety.

Conclusion: Navigating the Future of Breast Biopsy

As breast biopsy technology continues to evolve, the industry must embrace both innovation and collaboration. The convergence of imaging advancements, AI-driven guidance, and minimally invasive tools points toward a future in which diagnostics occur faster, with greater accuracy and patient comfort. To capitalize on this trajectory, stakeholders must align their strategic road maps with clinical imperatives, regulatory landscapes, and patient expectations. Cultivating partnerships across the healthcare continuum-from device manufacturers to pathology labs-will foster comprehensive solutions that address the full spectrum of diagnostic needs. By doing so, the sector can sustain growth, elevate standards of care, and ultimately improve outcomes for individuals undergoing breast biopsy procedures.

Market Segmentation & Coverage

This research report categorizes the Breast Biopsy Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • MRI-Guided Biopsy
    • Vacuum-Assisted Core Biopsy
  • Open Surgical Biopsy
    • Excisional Biopsy
    • Incisional Biopsy
  • Stereotactic Biopsy
    • 3D Mammography Biopsy
  • Ultrasound-Guided Biopsy
    • Core Needle Biopsy
    • Fine Needle Aspiration Biopsy
  • Biopsy Guidance Systems
    • Stereotactic Guidance Systems
    • Ultrasound-Based
  • Biopsy Guns
    • Automatic Biopsy Guns
    • Semi-Automatic Biopsy Guns
  • Biopsy Needles
    • Core Needles
    • Fine Needles
    • Vacuum-Assisted Needles
  • Diagnostic Applications
    • Cancer Detection
    • Pre-Cancerous Lesions Detection
  • Prognostic Applications
    • Disease Progression Monitoring
    • Therapy Efficacy Evaluation
  • Ambulatory Surgical Centers
    • Freestanding ASCs
    • Hospital-Affiliated ASCs
  • Diagnostic Centers
    • Private Diagnostic Centers
  • Hospitals
    • Public Sector
  • Non-Surgical Imaging Technologies
    • Digital Mammography
    • MRI
    • Ultrasound
  • Robotic-Assisted Biopsy Procedures
    • Automated Needle Control Systems
    • Precision Robotics

This research report categorizes the Breast Biopsy Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Breast Biopsy Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Argon Medical
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc
  • Biocept, Inc.
  • Cook Group Incorporated
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fluxion Biosciences Inc.
  • FUJIFILM Corporation
  • GE HealthCare
  • Guardant Health
  • Halma plc
  • Hologic, Inc.
  • Illumina, Inc.
  • INRAD, Inc.
  • Iskus Health Ltd.
  • Johnson & Johnson Services, Inc.
  • Leica Biosystems Nussloch GmbH
  • Medtronic PLC
  • Merit Medical Systems
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • TransMed7, LLC
  • Trivitron Healthcare

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Breast Biopsy Market, by Biopsy Technique
8.1. Introduction
8.2. MRI-Guided Biopsy
8.2.1. Vacuum-Assisted Core Biopsy
8.3. Open Surgical Biopsy
8.3.1. Excisional Biopsy
8.3.2. Incisional Biopsy
8.4. Stereotactic Biopsy
8.4.1. 3D Mammography Biopsy
8.5. Ultrasound-Guided Biopsy
8.5.1. Core Needle Biopsy
8.5.2. Fine Needle Aspiration Biopsy
9. Breast Biopsy Market, by Product Line
9.1. Introduction
9.2. Biopsy Guidance Systems
9.2.1. Stereotactic Guidance Systems
9.2.2. Ultrasound-Based
9.3. Biopsy Guns
9.3.1. Automatic Biopsy Guns
9.3.2. Semi-Automatic Biopsy Guns
9.4. Biopsy Needles
9.4.1. Core Needles
9.4.2. Fine Needles
9.4.3. Vacuum-Assisted Needles
10. Breast Biopsy Market, by Application
10.1. Introduction
10.2. Diagnostic Applications
10.2.1. Cancer Detection
10.2.2. Pre-Cancerous Lesions Detection
10.3. Prognostic Applications
10.3.1. Disease Progression Monitoring
10.3.2. Therapy Efficacy Evaluation
11. Breast Biopsy Market, by End-User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.2.1. Freestanding ASCs
11.2.2. Hospital-Affiliated ASCs
11.3. Diagnostic Centers
11.3.1. Private Diagnostic Centers
11.4. Hospitals
11.4.1. Public Sector
12. Breast Biopsy Market, by Technology
12.1. Introduction
12.2. Non-Surgical Imaging Technologies
12.2.1. Digital Mammography
12.2.2. MRI
12.2.3. Ultrasound
12.3. Robotic-Assisted Biopsy Procedures
12.3.1. Automated Needle Control Systems
12.3.2. Precision Robotics
13. Americas Breast Biopsy Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Breast Biopsy Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Breast Biopsy Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Argon Medical
16.3.2. Becton, Dickinson, and Company
16.3.3. Bio-Rad Laboratories, Inc
16.3.4. Biocept, Inc.
16.3.5. Cook Group Incorporated
16.3.6. CooperSurgical, Inc.
16.3.7. F. Hoffmann-La Roche Ltd.
16.3.8. Fluxion Biosciences Inc.
16.3.9. FUJIFILM Corporation
16.3.10. GE HealthCare
16.3.11. Guardant Health
16.3.12. Halma plc
16.3.13. Hologic, Inc.
16.3.14. Illumina, Inc.
16.3.15. INRAD, Inc.
16.3.16. Iskus Health Ltd.
16.3.17. Johnson & Johnson Services, Inc.
16.3.18. Leica Biosystems Nussloch GmbH
16.3.19. Medtronic PLC
16.3.20. Merit Medical Systems
16.3.21. Siemens Healthineers
16.3.22. Sysmex Corporation
16.3.23. Thermo Fisher Scientific Inc.
16.3.24. TransMed7, LLC
16.3.25. Trivitron Healthcare
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BREAST BIOPSY MARKET MULTI-CURRENCY
FIGURE 2. BREAST BIOPSY MARKET MULTI-LANGUAGE
FIGURE 3. BREAST BIOPSY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BREAST BIOPSY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BREAST BIOPSY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BREAST BIOPSY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED CORE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY EXCISIONAL BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY INCISIONAL BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D MAMMOGRAPHY BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION BIOPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC GUIDANCE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATIC BIOPSY GUNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATIC BIOPSY GUNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED NEEDLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BREAST BIOPSY MARKET SIZE, BY CANCER DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRE-CANCEROUS LESIONS DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BREAST BIOPSY MARKET SIZE, BY DISEASE PROGRESSION MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BREAST BIOPSY MARKET SIZE, BY THERAPY EFFICACY EVALUATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREESTANDING ASCS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITAL-AFFILIATED ASCS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC SECTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIGITAL MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED NEEDLE CONTROL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRECISION ROBOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 123. CANADA BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 124. CANADA BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 125. CANADA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 126. CANADA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 127. CANADA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 128. CANADA BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 129. CANADA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 130. CANADA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 131. CANADA BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 132. CANADA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. CANADA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 134. CANADA BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 135. CANADA BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. CANADA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 137. CANADA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 138. CANADA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 139. CANADA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. CANADA BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 141. CANADA BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 142. MEXICO BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 143. MEXICO BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 144. MEXICO BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 145. MEXICO BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 146. MEXICO BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 147. MEXICO BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 148. MEXICO BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 150. MEXICO BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 151. MEXICO BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. MEXICO BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 153. MEXICO BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 154. MEXICO BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. MEXICO BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 157. MEXICO BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 158. MEXICO BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. MEXICO BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 160. MEXICO BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES BREAST BIOPSY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 181. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 182. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 201. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 202. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 220. CHINA BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 221. CHINA BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 222. CHINA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 223. CHINA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 224. CHINA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 225. CHINA BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 226. CHINA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 227. CHINA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 228. CHINA BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 229. CHINA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. CHINA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 231. CHINA BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 232. CHINA BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. CHINA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 234. CHINA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 235. CHINA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 236. CHINA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. CHINA BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 238. CHINA BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 239. INDIA BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 240. INDIA BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 241. INDIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 242. INDIA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 243. INDIA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 244. INDIA BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 245. INDIA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 246. INDIA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 247. INDIA BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 248. INDIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. INDIA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 250. INDIA BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 251. INDIA BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. INDIA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 253. INDIA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 254. INDIA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. INDIA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. INDIA BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 257. INDIA BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 258. INDONESIA BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 259. INDONESIA BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 269. INDONESIA BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 270. INDONESIA BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. INDONESIA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 277. JAPAN BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 278. JAPAN BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 279. JAPAN BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 280. JAPAN BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 281. JAPAN BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 282. JAPAN BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 283. JAPAN BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 284. JAPAN BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 285. JAPAN BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 286. JAPAN BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. JAPAN BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 288. JAPAN BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 289. JAPAN BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 290. JAPAN BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 291. JAPAN BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 292. JAPAN BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 293. JAPAN BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 294. JAPAN BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 295. JAPAN BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 296. MALAYSIA BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 297. MALAYSIA BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 308. MALAYSIA BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 309. MALAYSIA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 310. MALAYSIA BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 311. MALAYSIA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 312. MALAYSIA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 313. MALAYSIA BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 314. MALAYSIA BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 315. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 316. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 317. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 318. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 319. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 320. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 321. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 322. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 323. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 324. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 325. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY NON-SURGICAL IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES BREAST BIOPSY MARKET SIZE, BY ROBOTIC-ASSISTED BIOPSY PROCEDURES, 2018-2030 (USD MILLION)
TABLE 334. SINGAPORE BREAST BIOPSY MARKET SIZE, BY BIOPSY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 335. SINGAPORE BREAST BIOPSY MARKET SIZE, BY MRI-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 336. SINGAPORE BREAST BIOPSY MARKET SIZE, BY OPEN SURGICAL BIOPSY, 2018-2030 (USD MILLION)
TABLE 337. SINGAPORE BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC BIOPSY, 2018-2030 (USD MILLION)
TABLE 338. SINGAPORE BREAST BIOPSY MARKET SIZE, BY ULTRASOUND-GUIDED BIOPSY, 2018-2030 (USD MILLION)
TABLE 339. SINGAPORE BREAST BIOPSY MARKET SIZE, BY PRODUCT LINE, 2018-2030 (USD MILLION)
TABLE 340. SINGAPORE BREAST BIOPSY MARKET SIZE, BY BIOPSY GUIDANCE SYSTEMS, 2018-2030 (USD MILLION)
TABLE 341. SINGAPORE BREAST BIOPSY MARKET SIZE, BY BIOPSY GUNS, 2018-2030 (USD MILLION)
TABLE 342. SINGAPORE BREAST BIOPSY MARKET SIZE, BY BIOPSY NEEDLES, 2018-2030 (USD MILLION)
TABLE 343. SINGAPORE BREAST BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 345. SINGAPORE BREAST BIOPSY MARKET SIZE, BY PROGNOSTIC APPLICATIONS, 2018-2030 (USD MILLION)
TABLE

Companies Mentioned

  • Argon Medical
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc
  • Biocept, Inc.
  • Cook Group Incorporated
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Fluxion Biosciences Inc.
  • FUJIFILM Corporation
  • GE HealthCare
  • Guardant Health
  • Halma plc
  • Hologic, Inc.
  • Illumina, Inc.
  • INRAD, Inc.
  • Iskus Health Ltd.
  • Johnson & Johnson Services, Inc.
  • Leica Biosystems Nussloch GmbH
  • Medtronic PLC
  • Merit Medical Systems
  • Siemens Healthineers
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • TransMed7, LLC
  • Trivitron Healthcare

Methodology

Loading
LOADING...

Related Topics

Related Reports

Breast Biopsy Device Market - Global Forecast to 2030 - Product Image

Breast Biopsy Device Market - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report By Technology, By End-use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Breast Cancer Core Needle Biopsy Market Size, Share & Trends Analysis Report By Technology, By End-use (Hospitals & Diagnostic Laboratories, Academic & Research Institutes), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2025-2033 - Product Image

Biopsy Devices Market Report by Procedure Type, Product, Application, Guidance Technique, End User, and Region 2025-2033

  • Report
  • 141 Pages
  • Global
From
Biopsy Guidance Systems Market Size, Share & Trends Analysis Report By Product (Stereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Biopsy Guidance Systems Market Size, Share & Trends Analysis Report By Product (Stereotactic Guided Biopsy, Ultrasound Guided Biopsy, MRI Guided Biopsy), By Application, By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.